- Home
- DCX vs TIVC Comparison
DCX vs TIVC Comparison
Compare DCX & TIVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DCX | TIVC |
|---|---|---|
| Founded | 2009 | 2016 |
| Country | China | United States |
| Employees | 1389 | N/A |
| Industry | Auto Manufacturing | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5M | 3.6M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | DCX | TIVC |
|---|---|---|
| Price | $2.30 | $1.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 9.1K | ★ 222.5K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $780,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.34 | $0.75 |
| 52 Week High | $5.68 | $5.60 |
Technical Indicators
Market Signals| Indicator | DCX | TIVC |
|---|---|---|
| Relative Strength Index (RSI) | 49.16 | 69.31 |
| Support Level | $2.05 | $0.79 |
| Resistance Level | $5.68 | $2.70 |
| Average True Range (ATR) | 0.27 | 0.11 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 35.79 | 100.00 |
Price Performance
Historical ComparisonAbout DCX Digital Currency X Technology Inc. Class A Ordinary Shares
Digital Currency X Technology Inc, formerly Chijet Motor Company Inc is engaged in the development, manufacture, sales, and service of new energy vehicles (NEV), hybrid vehicles and traditional fuel vehicles in China. New energy vehicles refer to plug-in electric vehicles, including battery electric vehicles, plug-in hybrid (PHEV) electric vehicles, and fuel cell electric vehicles. Its passenger vehicles include small cars, sedans, and sports utility vehicles, or SUVs, and commercial vehicles include light trucks and vans. The company generates all of its revenue from PRC.
About TIVC Tivic Health Systems Inc.
Tivic Health Systems Inc is a late-stage biopharmaceutical company focused on the development of biologics, with its lead product candidate, Entolimod, a TLR5 agonist, being developed for acute radiation syndrome and oncology-related indications. The company operates through two segments: a biopharma segment focused on product development and commercialization, and a contract development and manufacturing organization (CDMO) segment providing manufacturing and development services through its subsidiary.